Sree Rayalaseema Hi-Strength Hypo

Market Cap

962.09 Cr

EPS

46.01

PE Ratio

10.52

Dividend Yield

0.55 %

Industry

Chemicals

52 Week High

942.00

52 Week low

441.00

PB Ratio

1.07

Debt to Equity

0.02

Sector

Commodity Chemicals

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Company News

View All News

Sree Rayalaseema Hi-strength Hypo Reports Q3 Financial Results3 days ago

Sree Rayalaseema Hi-strength Hypo announced its Q3 financial results. The company reported a net profit of 235 million rupees, up from 166 million rupees in the same quarter last year. However, revenue decreased to 1.38 billion rupees from 2.1 billion rupees year-over-year.

Sree Rayalaseema Hi-Strength Hypo Reports Q3 EBITDA and Margin6 days ago

Sree Rayalaseema Hi-Strength Hypo announced its Q3 financial results. The company reported an EBITDA of 214 million rupees, compared to 222 million rupees in the same quarter last year. Despite the slight decrease in EBITDA, the company's EBITDA margin improved significantly to 15.43% from 10.33% year-over-year.

Sree Rayalaseema Hi-Strength Hypo Reports Q3 Financial Results6 days ago

Sree Rayalaseema Hi-Strength Hypo has announced its Q3 financial results. The company's net profit increased to 235 million rupees, up from 166 million rupees in the same quarter last year. However, revenue decreased to 1.38 billion rupees from 2.1 billion rupees year-over-year.

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Tata Chemicals	854.70	21,774.02	49.09	15,707.00	-7.64	449	-110.82	28.47
Deepak Fertilisers & Petrochemicals	1,065.30	13,448.12	14.99	8,798.90	-22.71	457	318.35	42.21
GNFC	551.15	8,098.64	15.56	8,398.90	-20.68	485	68.04	43.41
Chemplast Sanmar	411.00	6,498.30	-	4,003.40	-20.27	-158	45.41	37.80
Gujarat Heavy Chemicals	614.20	5,881.26	9.80	3,498.80	-23.68	794	68.74	34.79
Gujarat Alkalies & Chemicals	582.00	4,274.51	-	3,896.70	-14.52	-237	90.27	18.74
Fischer Medical Ventures	779.95	4,172.72	-	21.50	10,650.00	2	62.50	64.97
Grauer & Weil	91.40	4,144.19	25.78	1,099.90	9.90	146	0.70	42.91
Tanfac Industries	3,400.00	3,391.49	42.61	385.20	0.60	53	244.55	51.20
Thirumalai Chemicals	234.97	2,405.81	-	2,102.50	-2.77	-39	-82.61	35.92

Growth Rate

Revenue Growth

-47.26 %

Net Income Growth

-48.80 %

Cash Flow Change

-1.22 %

ROE

-52.00 %

ROCE

-46.15 %

EBITDA Margin (Avg.)

17.27 %

Quarterly Financial Results

Quarterly Financials	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Revenue	90	75	96	106	95	175	162	174	182	196	204	207	310	289	272	296	421	570	347	312	455	262	228	225	174	171	179	151
Expenses	82	66	85	89	83	150	137	145	157	163	168	171	280	260	239	245	372	517	310	275	371	226	199	198	143	143	141	119
EBITDA	8	9	11	17	13	24	26	30	25	33	36	37	31	30	34	51	49	54	37	37	85	36	29	27	31	28	38	32
Operating Profit %	9 %	10 %	11 %	15 %	13 %	14 %	16 %	16 %	13 %	17 %	17 %	18 %	9 %	9 %	12 %	17 %	10 %	9 %	10 %	9 %	15 %	13 %	12 %	8 %	13 %	15 %	17 %	14 %
Depreciation	2	2	3	3	6	13	13	13	13	13	13	13	13	5	5	5	5	4	5	5	5	3	3	3	3	2	2	2
Interest	2	3	2	2	2	2	2	2	3	2	2	1	0	1	1	5	0	0	1	0	1	1	1	1	2	1	0	0
Profit Before Tax	3	3	6	13	0	10	11	15	10	19	22	23	17	24	28	41	44	49	31	32	79	33	25	24	26	26	36	30
Tax	-1	-1	-1	4	-3	2	3	5	-2	5	6	6	4	6	7	15	7	13	8	8	7	8	7	7	6	7	11	9
Net Profit	5	4	7	9	3	8	8	11	11	14	16	17	14	18	21	27	37	36	24	24	71	24	19	17	20	19	25	22
EPS in ₹	3.06	2.89	4.91	5.77	2.05	4.61	4.73	6.12	6.62	7.92	9.42	10.04	7.91	10.60	12.04	15.49	21.75	20.93	13.81	13.70	41.43	14.16	10.77	9.69	11.39	10.85	14.74	12.56

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2016	2017	2020	2021	2022	2023	2024
Total Assets	372	340	445	519	788	945	914
Fixed Assets	195	188	162	134	130	105	128
Current Assets	119	115	248	314	482	554	529
Capital Work in Progress	2	0	3	0	0	14	0
Investments	0	0	18	50	164	268	253
Other Assets	176	153	262	334	495	558	534
Total Liabilities	372	340	445	519	788	945	914
Current Liabilities	115	83	115	119	205	133	54
Non Current Liabilities	54	61	18	13	13	61	59
Total Equity	204	197	312	388	570	751	801
Reserve & Surplus	189	182	294	371	553	734	783
Share Capital	15	15	17	17	17	17	17

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2016	2017	2020	2021	2022	2023	2024
Net Cash Flow	-0	2	40	-35	7	13	103
Investing Activities	-10	-1	-38	-115	-1	-112	-20
Operating Activities	21	-8	99	71	60	141	140
Financing Activities	-12	11	-22	10	-51	-17	-17

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Sept 2018	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Promoter	61.68 %	62.05 %	62.05 %	62.09 %	62.09 %	62.09 %	62.09 %	62.09 %	62.09 %	62.09 %	62.09 %	62.09 %	61.84 %	61.84 %	61.84 %	61.84 %	61.84 %
FIIs	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.65 %	0.57 %	0.56 %	0.14 %	0.08 %
DIIs	0.04 %	0.04 %	0.04 %	0.04 %	0.04 %	0.04 %	0.04 %	0.04 %	0.04 %	0.04 %	0.03 %	0.03 %	0.03 %	0.03 %	0.05 %	0.03 %	0.03 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	30.44 %	30.46 %	30.47 %	31.06 %	31.15 %	31.14 %	31.26 %	30.73 %	30.85 %	30.93 %	25.75 %	25.82 %	26.10 %	25.89 %	25.62 %	26.11 %	26.26 %
Others	7.84 %	7.45 %	7.44 %	6.81 %	6.71 %	6.73 %	6.61 %	7.14 %	7.02 %	6.94 %	12.12 %	12.05 %	11.38 %	11.67 %	11.93 %	11.88 %	11.78 %
No of Share Holders	57,923	58,036	58,223	59,553	59,522	59,058	59,283	62,802	64,522	65,045	47,181	48,576	48,539	47,510	46,565	45,411	45,959